|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1001 19th Street N |
Address2 | Suite 1002 |
City | Arlington |
State | VA |
Zip Code | 22209 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Arlington |
State | VA |
Zip Code | 22205 |
Country | USA |
|
5. Senate ID# 319756-48
|
||||||||
|
6. House ID# 394770001
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Elise A Elliott |
Date | 4/20/2022 3:16:20 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HCR - Health Issues3/10/2022Meeting w/ agency staff on surprise medical bill rulemaking
HCR - Health Issues1/24/2022Meeting w/ Ways and Means Majority staff regarding at home COVID testing
HCR - Health Issues1/26/2022Meeting w/House Mental Health Caucus staff on mental health
HCR - Health Issues1/27/2022Meeting w/ House Ed & Labor Committee Majority staff re at home COVID testing
HCR - Health Issues1/27/2022Meeting w/ E&C Committee Majority staff on at home COVID testing
HCR - Health Issues2/15/2022Meeting w/ Rep. Kurt Schrader on mental health issues
HCR - Health Issues3/2/2022Meeting w/ Rep. Schrier on mental health issues
HCR - Health Issues3/18/2022Meeting w/ Ed & Labor Majority on mental health civil monetary penalties
HCR - Health Issues3/22/2022Meeting w/ Ed & Labor Minority on mental health civil monetary penalties
HCR - Health Issues3/30/2022Meeting w/ agency staff on surprise medical bill rulemaking
HCR - Health Issues3/31/2022Meeting w/ OIRA staff on surprise medical bill rulemaking
HCR - Health Issues1/25/2022Meeting w/ Senator Cortez Masto staff on Health Savings Accounts
HCR - Health Issues1/25/2022Meeting w/ Senator Carper staff on Health Savings Accounts
HCR - Health Issues1/26/2022Meeting w/ Finance Committee Majority staff regarding at home COVID testing
HCR - Health Issues1/28/2022Meeting w/ Senate HELP Committee staff on at home COVID testing
HCR - Health Issues2/16/2022Meeting w/ Senate HELP staff to discuss Bipartisan Legislation re Mental Health and Substance Use Disorder Programs
HCR - Health Issues2/16/2022Meeting w/ Senate HELP Committee staff on mental health issues
HCR - Health Issues3/4/2022Meeting w/ Danielle Janowski (Sen. Thune) to discuss Bipartisan Legislation re Mental Health Care Access
HCR - Health Issues3/4/2022Meeting w/ Se. Thune's staff on mental health and telehealth issues
HCR - Health Issues3/11/2022Meeting w/ HELP Committee staff to discuss Bipartisan Legislation re Mental Health Care Access
HCR - Health Issues3/11/2022Meeting w/ Senate HELP Committee staff on mental health issues
HCR - Health Issues3/24/2022Meeting with Sen. Schumer's staff on health care issues
HCR - Health Issues3/30/2022Meeting w/ DPC staff on surprise medical bill rulemaking
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Labor - Dept of (DOL), Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Timothy |
Bartl |
|
Rep. Steve Gunderson-Legislative Director/Counsel, Leg. Assistant, Leg. Correspondent |
|
Margaret |
Faso |
|
|
|
Daniel |
Chasen |
|
Rep. Chuck Fleischmann, Intern |
|
Chatrane |
Birbal |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
LBR - Labor Issues/Antitrust/Workplace3/15/2022Letter to USDA regarding Agriculture Acquisition Regulation Proposed Rule
LBR - Labor Issues/Antitrust/Workplace3/9/2022Meeting w/ EEOC Commissioner Lucas to discuss workplace topics/HR Policy priority issues
LBR - Labor Issues/Antitrust/Workplace1/14/2022Meeting w/ Rep. Stefanik staff regarding H.R. 5743/S.3074, the Ensuring Workers Get PAID Act
LBR - Labor Issues/Antitrust/Workplace1/25/2022Letter to DOL to Engage Stakeholders on New Overtime Regulations
LBR - Labor Issues/Antitrust/Workplace3/18/2022Meeting w/ DOL staff Overtime rulemaking
LBR - Labor Issues/Antitrust/Workplace1/14/2022Letter to the Senate in support of S. 3143, the Resolving Sexual Assault and Harassment Disputes Act
LBR - Labor Issues/Antitrust/Workplace2/8/2022Meeting w/ Senator Ernst staff regarding H.R.4445, the Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act
LBR - Labor Issues/Antitrust/Workplace3/17/2022Meeting w/ Senator Capito's staff to discuss FAIR Act S.505/H.R.963 (Arbitration Bill)
LBR - Labor Issues/Antitrust/Workplace3/18/2022Meeting w/ Senator Blackburn's staff to discuss FAIR Act S.505/H.R.963 (Arbitration Bill)
LBR - Labor Issues/Antitrust/Workplace3/18/2022Meeting w/ Senator Murkowski's staff to discuss FAIR Act S.505/H.R.963 (Arbitration Bill)
LBR - Labor Issues/Antitrust/Workplace1/14/2022Submitted comments to the White House's Office of Science and Technology Policy (OSTP) re AI in the workplace
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Equal Employment Opportunity Commission (EEOC), Labor - Dept of (DOL), White House Office, Securities & Exchange Commission (SEC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
TIMOTHY |
BARTL |
|
Rep. Steve Gunderson-Legislative Director/Counsel, Leg.
Assistant, Leg. Correspondent |
|
Margaret |
Faso |
|
|
|
Daniel |
Chasen |
|
Rep. Chuck Fleischmann, Intern |
|
Chatrane |
Birbal |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIN
16. Specific lobbying issues
FIN - Financial Institutions/Investments/Securities3/2/2022Meeting w/ GAO staff regarding the business use of Non-Compete Agreements
FIN - Financial Institutions/Investments/Securities1/18/2022Meeting w/ Corey Klemmer to discuss anticipated rulemaking on human capital metrics
FIN - Financial Institutions/Investments/Securities3/4/2022Submitted comments to the SEC regarding Pay for Performance
FIN - Financial Institutions/Investments/Securities3/10/2022Meeting with Chair Gensler and policy staff regarding 10b5-1 plan rules, pay versus performance, human capital disclosure, proxy advisory rules, and board governance
FIN - Financial Institutions/Investments/Securities2/16/2022Meeting w/ Nancy Martinez (Senator Young) to discuss S.483/H.R.1367, the Workforce Mobility Act
FIN - Financial Institutions/Investments/Securities3/2/2022Meeting w/ Senate HELP staff to discuss Non-Compete Agreements and S.483/H.R.1367 Workforce Mobility Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Government Accountability Office (GAO), U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
TIMOTHY |
BARTL |
|
|
|
Margaret |
Faso |
|
|
|
Daniel |
Chasen |
|
Rep. Chuck Fleischmann, Intern |
|
Chatrane |
Birbal |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
Jazz Pharmaceuticals, Inc. |
|
|
2342.40 | 0 % |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 Michelin North America, Inc. | 3 Flex | 5 |
2 Sony Music Entertainment | 4 Chubb Group | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |